BOBULSKY SUSAN (SVP, Diagnostics, clonoSEQ) sold 0.8% of their position (3K shares) of ADAPTIVE BIOTECHNOLOGIES CORP on the open market
Open‑market sale worth $75.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/12/2026ACC: 0001820885-26-000020
Officer· SVP, Diagnostics, clonoSEQ
Since Aug 2020
-3K
Net shares
Net seller
$75.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3K
Price / share
$25.00
Trade value
$75K
% of position
0.8%
8/10/2026
399.99K→396.99K
Total
Net shares
−3K
Net value
-$75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/10/2026 | S · Sale | −3K | $25.00 | $75K | 0.8% | 399.99K | 396.99K |
| Total | −3K | -$75K | ||||||
Derivative Transactions0
No derivative transactions reported